XOMAP Q3 2025 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+29.9% YoY

Gross Profit

$8M90.6% margin

Operating Income

-$1M-14.2% margin

Net Income

$14M150.3% margin

EPS (Diluted)

$0.70

QoQ Revenue Growth

-28.8%

Cash Flow

Operating Cash Flow

-$295,999

Free Cash Flow

-$296,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$263M

Total Liabilities

$155M

Stockholders' Equity

$108M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$7M	+29.9%
Gross Profit	$8M	$7M	+17.7%
Operating Income	-$1M	-$16M	+91.5%
Net Income	$14M	-$17M	+181.5%

Geographic Segments

SWITZERLAND

$7M50%

Asia Pacific

$4M30%

UNITED STATES

$3M20%